ENTRY       D00343                      Drug
NAME        Ifosfamide (JAN/USP/INN);
            Ifex (TN)
PRODUCT     IFOSFAMIDE (Baxter Healthcare Corporation) 91e433a9-6800-43a6-ac13-a49a04a5aecd
            IFEX (Baxter Healthcare Corporation) b7241707-7538-4d1a-91e7-3a25a91e0b9a
  GENERIC   IFOSFAMIDE (APP Pharmaceuticals) f6fef680-884f-46fc-bf81-0ef7c5db6f32
            IFOSFAMIDE (Fresenius Kabi USA) a311a947-7b78-4226-bfe0-f4aa0be20e27
            IFOSFAMIDE (Fresenius Kabi USA) fb7f49af-ffe9-4969-a69c-8ed14dd0616b
            IFOSFAMIDE (Mylan Institutional LLC) 27f666d5-0d49-42d4-be52-ad8505593f48
            IFOSFAMIDE (Mylan Institutional LLC) 9273052f-cd52-4452-b3eb-a78984b852ad
            IFOSFAMIDE (Pfizer Laboratories Div Pfizer) 0a7099a9-5c9a-409e-b6f4-c31812a43327
            IFOSFAMIDE (Teva Parenteral Medicines) 14f535d7-4593-4cee-94fb-54ee239d95d2
FORMULA     C7H15Cl2N2O2P
EXACT_MASS  260.0248
MOL_WEIGHT  261.086
CLASS       Antineoplastic
             DG01677  Alkylating agent
              DG01678  Nitrogen mustard analogue
               DG01720  Isophosphoramide mustard analogue
            Cyp substrate
             DG01633  CYP3A substrate
REMARK      Same as: C07047
            Therapeutic category: 4211
            ATC code: L01AA06
            Chemical group: DG02165
ACTIVITY    Antineoplastic, Alkylating agent
  DISEASE   Testicular cancer [DS:H00023]
COMMENT     Active form of prodrug: 4-Hydroxyifosfamide [CPD:C16553]
TARGET      DNA
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555]
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AA Nitrogen mustard analogues
                 L01AA06 Ifosfamide
                  D00343  Ifosfamide (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4211  Chlorethylamines
                 D00343  Ifosfamide (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Others
              Nucleic acid
               DNA
                Ifosfamide
                 D00343  Ifosfamide (JAN/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP substrates
              CYP2B6
               Ifosfamide
                D00343  Ifosfamide (JAN/USP/INN)
              CYP3A4
               Ifosfamide
                D00343  Ifosfamide (JAN/USP/INN)
            Antineoplastics [br08340.html]
             D00343
            Orphan drugs in the USA [br08355.html]
             Orphan drugs in the USA
              D00343
DBLINKS     CAS: 3778-73-2
            PubChem: 7847409
            ChEBI: 5864
            ChEMBL: CHEMBL1024
            DrugBank: DB01181
            LigandBox: D00343
            NIKKAJI: J2.196B
ATOM        14
            1   P1a P    27.8304  -19.5949
            2   N1b N    27.8362  -18.1152
            3   N1y N    28.9741  -20.2612
            4   O2x O    26.6807  -20.2612
            5   O3b O    26.5511  -18.8521
            6   C1x C    28.9741  -21.5877
            7   C1x C    26.6807  -21.5877
            8   C1x C    27.8304  -22.2421
            9   C1b C    30.1794  -19.5230
            10  C1b C    31.4045  -20.2302
            11  X   Cl   32.6294  -19.5230
            12  C1b C    26.6476  -17.4300
            13  C1b C    25.4351  -18.1300
            14  X   Cl   24.2227  -17.4300
BOND        14
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 2
            5     3   6 1
            6     4   7 1
            7     6   8 1
            8     7   8 1
            9     3   9 1
            10    9  10 1
            11   10  11 1
            12    2  12 1
            13   12  13 1
            14   13  14 1
///
